These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2305178)

  • 1. In vitro antibacterial activity of bismuth subsalicylate.
    Cornick NA; Silva M; Gorbach SL
    Rev Infect Dis; 1990; 12 Suppl 1():S9-10. PubMed ID: 2305178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.
    Manhart MD
    Rev Infect Dis; 1990; 12 Suppl 1():S11-5. PubMed ID: 2406851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.
    Pitz AM; Park GW; Lee D; Boissy YL; Vinjé J
    Gut Microbes; 2015; 6(2):93-100. PubMed ID: 25901890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
    Domenico P; Landolphi DR; Cunha BA
    J Antimicrob Chemother; 1991 Dec; 28(6):801-10. PubMed ID: 1816178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bismuth subsalicylate on fecal microflora.
    Gorbach SL; Cornick NA; Silva M
    Rev Infect Dis; 1990; 12 Suppl 1():S21-3. PubMed ID: 2305174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile.
    Mahony DE; Woods A; Eelman MD; Burford N; Veldhuyzen van Zanten SJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):431-3. PubMed ID: 15616328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications.
    Vega-Jiménez AL; Almaguer-Flores A; Flores-Castañeda M; Camps E; Uribe-Ramírez M; Aztatzi-Aguilar OG; De Vizcaya-Ruiz A
    Nanotechnology; 2017 Oct; 28(43):435101. PubMed ID: 28837052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding and killing of bacteria by bismuth subsalicylate.
    Sox TE; Olson CA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2075-82. PubMed ID: 2694949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa.
    Domenico P; O'Leary R; Cunha BA
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):170-5. PubMed ID: 1396732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.
    Andreasen JJ; Andersen LP
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):147-9. PubMed ID: 3591312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bismuth subsalicylate in the prevention of colonization of infant mice with Campylobacter jejuni.
    Hänninen ML
    Epidemiol Infect; 1990 Jun; 104(3):397-404. PubMed ID: 2347383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.
    Gump DW; Nadeau OW; Hendricks GM; Meyer DH
    Med Microbiol Immunol; 1992; 181(3):131-43. PubMed ID: 1522823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid.
    Kappstein I; Engels I
    Eur J Clin Microbiol; 1987 Apr; 6(2):216-7. PubMed ID: 3595590
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin.
    Horowitz NS; Staats HF; Palker TJ
    Immunopharmacology; 1995 Nov; 31(1):31-41. PubMed ID: 8655289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigation of in vitro hydrogen sulfide production using bismuth subsalicylate with and without monensin in beef feedlot diets.
    Ruiz-Moreno M; Binversie E; Fessenden SW; Stern MD
    J Anim Sci; 2015 Nov; 93(11):5346-54. PubMed ID: 26641054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bismuth subsalicylate increases intracellular Ca2+, MAP-kinase activity, and cell proliferation in normal human gastric mucous epithelial cells.
    Gilster J; Bacon K; Marlink K; Sheppard B; Deveney C; Rutten M
    Dig Dis Sci; 2004 Mar; 49(3):370-8. PubMed ID: 15139483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of gastroprotection by bismuth subsalicylate against chemically induced oxidative stress in cultured human gastric mucosal cells.
    Bagchi D; McGinn TR; Ye X; Balmoori J; Bagchi M; Stohs SJ; Kuszynski CA; Carryl OR; Mitra S
    Dig Dis Sci; 1999 Dec; 44(12):2419-28. PubMed ID: 10630491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth subsalicylate incorporated in polycaprolactone-gelatin membranes by electrospinning to prevent bacterial colonization.
    Vidal-Gutiérrez X; Prado-Prone G; Rodil SE; Velasquillo C; Clemente I; Silva-Bermudez P; Almaguer-Flores A
    Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34038883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.